The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
Biology of Platelet-Derived Growth Factor and Its Involvement in Disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
Demetri, G. D., von Mehren, M., Blanke, C. D., Van den Abbeele, A. D., Eisenberg, B., Roberts, P. J., Heinrich, M. C., Tuveson, D. A., Singer, S., Janicek, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020461 · Cited by 4,389
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
Hicklin, D. J., & Ellis, L. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.081 · Cited by 3,007
Enzinger and Weiss's Soft Tissue Tumors
Weiss, S. W., & Goldblum, J. R. (2001) · Cited by 2,510
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
Heldin, C.-H., & Westermark, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1283 · Cited by 2,496
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
Heinrich, M. C., Corless, C. L., Duensing, A., McGreevey, L., Chen, C.-J., Joseph, N., Singer, S., Griffith, D. J., Haley, A., Town, A., et al. (2003) · Science · doi:10.1126/science.1079666 · Cited by 2,301
Signaling Through Scaffold, Anchoring, and Adaptor Proteins
Pawson, T., & Scott, J. D. (1997) · Science · doi:10.1126/science.278.5346.2075 · Cited by 2,256
Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice
Lindahl, P., Johansson, B. R., Levéen, P., & Betsholtz, C. (1997) · Science · doi:10.1126/science.277.5323.242 · Cited by 2,226
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Jain, R. K. (2001) · Nature Medicine · doi:10.1038/nm0901-987 · Cited by 2,184
On the Absorption of Fluids from the Connective Tissue Spaces
Starling, E. H. (1896) · The Journal of Physiology · doi:10.1113/jphysiol.1896.sp000596 · Cited by 2,148
Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,966
Mendel, D. B., Laird, A., Xin, X., Louie, S. G., Christensen, J. G., Li, G., Schreck, R., Abrams, T. J., Ngai, T. J., Lee, L. B., et al. (2003) · PubMed · Cited by 1,961
Phosphatidylinositol-3-OH kinase direct target of Ras
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., & Downward, J. (1994) · Nature · doi:10.1038/370527a0 · Cited by 1,954
Ross, R., Glomset, J., Kariya, B., & Harker, L. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.4.1207 · Cited by 1,847
— Tumors of the Central Nervous System
(2013) · Pediatric Radiotherapy Planning and Treatment · doi:10.1201/b14554-7 · Cited by 1,751
Cools, J., DeAngelo, D. J., Gotlib, J., Stover, E. H., Legare, R. D., Cortes, J., Kutok, J., Clark, J., Galinsky, I., Griffin, J. D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025217 · Cited by 1,718
Self-citationVerweij, J., Casali, P. G., Zalcberg, J., LeCesne, A., Reichardt, P., Blay, J.-Y., Issels, R., van Oosterom, A., Hogendoorn, P. C., Van Glabbeke, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17098-0 · Cited by 1,665
DeAngelis, L. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101113440207 · Cited by 1,663
Motzer, R. J., Michaelson, M. D., Redman, B. G., Hudes, G. R., Wilding, G., Figlin, R. A., Ginsberg, M. S., Kim, S. T., Baum, C. M., DePrimo, S. E., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2574 · Cited by 1,634
Doolittle, R. F., Hunkapiller, M. W., Hood, L. E., Devare, S. G., Robbins, K. C., Aaronson, S. A., & Antoniades, H. N. (1983) · Science · doi:10.1126/science.6304883 · Cited by 1,536
The Molecular and Cellular Biology of Wound Repair
(1988) · Springer eBooks · doi:10.1007/978-1-4615-1795-5 · Cited by 1,516
The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
Flier, J. S., Underhill, L. H., & Friedman, S. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282508 · Cited by 1,432
Requirement for Phosphatidylinositol-3 Kinase in the Prevention of Apoptosis by Nerve Growth Factor
Yao, R., & Cooper, G. M. (1995) · Science · doi:10.1126/science.7701324 · Cited by 1,391
Bergers, G., Song, S., Meyer-Morse, N., Bergsland, E., & Hanahan, D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17929 · Cited by 1,370
Benjamin, L. E., Hemo, I., & Keshet, E. (1998) · Development · doi:10.1242/dev.125.9.1591 · Cited by 1,265
van Oosterom, A. T., Judson, I., Verweij, J., Stroobants, S., di Paola, E. D., Dimitrijevic, S., Martens, M., Webb, A., Sciot, R., Van Glabbeke, M., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06535-7 · Cited by 1,264
The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature.
Chusid, M. J., Dale, D. C., West, B. C., & Wolff, S. M. (1975) · PubMed · Cited by 1,233
Biology of Gastrointestinal Stromal Tumors
Corless, C. L., Fletcher, J. A., & Heinrich, M. C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.140 · Cited by 1,224
Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189
Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities.
Levéen, P., Pekny, M., Gebre-Medhin, S., Swolin, B., Larsson, E., & Betsholtz, C. (1994) · Genes & Development · doi:10.1101/gad.8.16.1875 · Cited by 1,131
SIGNALLING BY RECEPTOR TYROSINE KINASES
Fantl, W. J., Johnson, D. E., & Williams, L. T. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002321 · Cited by 1,086
THE HYPEREOSINOPHILIC SYNDROME: Analysis of Fourteen Cases With Review of The Literature
CHUSID, M. J., DALE, D. C., WEST, B. C., & WOLFF, S. M. (1975) · Medicine · doi:10.1097/00005792-197501000-00001 · Cited by 1,078
Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Müller, M., Druker, B. J., & Lydon, N. (1996) · PubMed · Cited by 1,057
Chordoma: incidence and survival patterns in the United States, 1973–1995
McMaster, M. L., Goldstein, A. M., Bromley, C. M., Ishibe, N., & Parry, D. M. (2001) · Cancer Causes & Control · doi:10.1023/a:1008947301735 · Cited by 966
Phosphoinositide 3-kinases: A conserved family of signal transducers
Vanhaesebroeck, B., Leevers, S. J., Panayotou, G., & Waterfield, M. D. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01061-x · Cited by 954
PLATELET-DERIVED GROWTH FACTOR
Ross, R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92760-8 · Cited by 940
The idiopathic hypereosinophilic syndrome
Weller, P., & Bubley, G. (1994) · Blood · doi:10.1182/blood.v83.10.2759.2759 · Cited by 929
Diabetes and atherosclerosis: An epidemiologic view
Pyörälä, K., Laakso, M., & Uusitupa, M. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030206 · Cited by 919
The Myeloproliferative Disorders
Campbell, P. J., & Green, A. R. (2006) · New England Journal of Medicine · doi:10.1056/nejmra063728 · Cited by 915
PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis
Boström, H., Willetts, K., Pekny, M., Levéen, P., Lindahl, P., Hedstrand, H., Pekna, M., Hellström, M., Gebre-Medhin, S., Schalling, M., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81270-2 · Cited by 864
Gastrointestinal stromal tumors: Recent advances in understanding of their biology
Miettinen, M., Sarlomo-Rikala, M., & Lasota, J. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90040-0 · Cited by 840
The PDGF family: four gene products form five dimeric isoforms
Fredriksson, L., Li, H., & Eriksson, U. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.007 · Cited by 838
Pinkas-Kramarski, R., Soussan, L., Waterman, H., Levkowitz, G., Alroy, I., Klapper, L., Lavi, S., Seger, R., Ratzkin, B. J., Sela, M., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00603.x · Cited by 769
(1990) · PubMed · Cited by 757
Myelofibrosis with Myeloid Metaplasia
Tefferi, A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004273421706 · Cited by 740
Lee, C. G., Heijn, M., di Tomaso, E., Griffon, G., Ancukiewicz, M., Koike, C., Park, K. R., Ferrara, N., Jain, R. K., Suit, H. D., et al. (2000) · PubMed · Cited by 677
The molecular and cellular biology of wound repair
Naylor, I. (1996) · British Journal of Plastic Surgery · doi:10.1016/s0007-1226(96)90047-8 · Cited by 667
Apperley, J. F., Gardembas, M., Melo, J. V., Russell-Jones, R., Bain, B. J., Baxter, E. J., Chase, A., Chessells, J. M., Colombat, M., Dearden, C. E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020150 · Cited by 630
PDGF-C is a new protease-activated ligand for the PDGF α-receptor
Li, X., Pontén, A., Aase, K., Karlsson, L., Abramsson, A., Uutela, M., Bäckström, G., Hellström, M., Boström, H., Li, H., et al. (2000) · Nature Cell Biology · doi:10.1038/35010579 · Cited by 623
Steed, D. L., & Study Group *, T. D. U. (1995) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(95)70245-8 · Cited by 612
Participants, R. T. (1993) · The Lancet · doi:10.1016/0140-6736(93)90348-k · Cited by 598
Isolation of a Novel Receptor cDNA Establishes the Existence of Two PDGF Receptor Genes
Matsui, T., Heidaran, M., Miki, T., Popescu, N., La Rochelle, W., Kraus, M., Pierce, J., & Aaronson, S. (1989) · Science · doi:10.1126/science.2536956 · Cited by 596
Dissecting tumour pathophysiology using intravital microscopy
Jain, R. K., Munn, L. L., & Fukumura, D. (2002) · Nature Reviews Cancer · doi:10.1038/nrc778 · Cited by 595
Enzinger and Weiss's Soft Tissue Tumors. 4th ed.
Mindell, E. R. (2001) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200111000-00036 · Cited by 585
Roles of PDGF in animal development
Hoch, R. V., & Soriano, P. (2003) · Development · doi:10.1242/dev.00721 · Cited by 585
Bork, P., & Beckmann, G. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1305 · Cited by 581
Daniels, C. E., Wilkes, M. C., Edens, M., Kottom, T. J., Murphy, S. J., LIMPER, A. H., & Leof, E. B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19603 · Cited by 574
PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor
Bergsten, E., Uutela, M., Li, X., Pietras, K., Östman, A., Heldin, C.-H., Alitalo, K., & Eriksson, U. (2001) · Nature Cell Biology · doi:10.1038/35074588 · Cited by 562
Ras-Dependent Induction of Cellular Responses by Constitutively Active Phosphatidylinositol-3 Kinase
Hu, Q., Klippel, A., Muslin, A. J., Fantl, W. J., & Williams, L. T. (1995) · Science · doi:10.1126/science.7701328 · Cited by 548
Simon, M.-P., Pedeutour, F., Sirvent, N., Grosgeorge, J., Minoletti, F., Coindre, J.-M., Terrier-Lacombe, M.-J., Mandahl, N., Craver, R., Blin, N., et al. (1997) · Nature Genetics · doi:10.1038/ng0197-95 · Cited by 535
Vascular development: cellular and molecular regulation
Beck, L., & D'Amore, P. A. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.5.9141503 · Cited by 519
Fiedler, W., Serve, H., Döhner, H., Schwittay, M., Ottmann, O. G., O'Farrell, A.-M., Bello, C. L., Allred, R., Manning, W. C., Cherrington, J. M., et al. (2005) · Blood · doi:10.1182/blood-2004-05-1846 · Cited by 490
Rugo, H. S., Herbst, R. S., Liu, G., Park, J. W., Kies, M. S., Steinfeldt, H. M., Pithavala, Y. K., Reich, S. D., Freddo, J. L., & Wilding, G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.192 · Cited by 486
McArthur, G. A., Demetri, G. D., van Oosterom, A., Heinrich, M. C., Debiec-Rychter, M., Corless, C. L., Nikolova, Z., Dimitrijevic, S., & Fletcher, J. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.088 · Cited by 482
Pietras, K., & Hanahan, D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.093 · Cited by 479
Pinzani, M., Gesualdo, L., Sabbah, G. M., & Abboud, H. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114363 · Cited by 478
Johnson, R. J., Iida, H., Alpers, C. E., Majesky, M. W., Schwartz, S. M., Pritzi, P., Gordon, K., & Gown, A. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115089 · Cited by 460
Heinrich, M. C., Rubin, B. P., Longley, B. J., & Fletcher, J. A. (2002) · Human Pathology · doi:10.1053/hupa.2002.124124 · Cited by 455
Pietras, K., Östman, A., SJÖQUIST, M., Buchdunger, E., Reed, R. K., Heldin, C., & Rubin, K. (2001) · PubMed · Cited by 450
Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice
Fruttiger, M., Karlsson, L., Hall, A. C., Abramsson, A., Calver, A. R., Boström, H., Willetts, K., Bertold, C.-H., Heath, J. K., Betsholtz, C., et al. (1999) · Development · doi:10.1242/dev.126.3.457 · Cited by 441
Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy.
Pietras, K., Rubin, K., Sjöblom, T., Buchdunger, E., Sjöquist, M., Heldin, C., & Östman, A. (2002) · PubMed · Cited by 433
Lokker, N. A., Sullivan, C. M., Hollenbach, S. J., Israel, M. A., & Giese, N. A. (2002) · PubMed · Cited by 429
Plattner, R., Kadlec, L., DeMali, K. A., Kazlauskas, A., & Pendergast, A. M. (1999) · Genes & Development · doi:10.1101/gad.13.18.2400 · Cited by 427
Lindahl, P., Karlsson, L., Hellström, M., Gebre-Medhin, S., Willetts, K., Heath, J. K., & Betsholtz, C. (1997) · Development · doi:10.1242/dev.124.20.3943 · Cited by 420
PDGF-D, a new protease-activated growth factor
LaRochelle, W. J., Jeffers, M., McDonald, W. F., Chillakuru, R. A., Giese, N. A., Lokker, N. A., Sullivan, C., Boldog, F. L., Yang, M., Vernet, C., et al. (2001) · Nature Cell Biology · doi:10.1038/35074593 · Cited by 402
Johnson, R. J., Raines, E. W., Floege, J., Yoshimura, A., Pritzl, P., Alpers, C., & Ross, R. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1413 · Cited by 341
Kilic, T., Alberta, J. A., Zdunek, P. R., Acar, M., Iannarelli, P., O'Reilly, T., Buchdunger, E., Black, P. M., & Stiles, C. D. (2000) · PubMed · Cited by 310
Guha, A. R., Dashner, K., Black, P. L. M., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600206 · Cited by 296
Iida, H., Seifert, R., Alpers, C. E., Gronwald, R. G., Phillips, P. E., Pritzl, P., Gordon, K., Gown, A. M., Ross, R., & Bowen-Pope, D. F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6560 · Cited by 293
Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts
Heldin, P., Laurent, T. C., & Heldin, C. H. (1989) · Biochemical Journal · doi:10.1042/bj2580919 · Cited by 291
Uusitupa, M. I., Niskanen, L. K., Siitonen, O., Voutilainen, E., & Pyörälä, K. (1990) · Circulation · doi:10.1161/01.cir.82.1.27 · Cited by 291
Shimizu, A., O'Brien, K. P., Sjöblom, T., et al. (1999) · PubMed · Cited by 289
Pinzani, M., Milani, S., Herbst, H., DeFranco, R., Grappone, C., Gentilini, A., Caligiuri, A., Pellegrini, G., Ngo, D. V., Romanelli, R. G., et al. (1996) · Europe PMC (PubMed Central) · Cited by 286
Sjöblom, T., Shimizu, A., O'Brien, K. P., Pietras, K., Cin, P. D., Buchdunger, E., Dumanski, J. P., Östman, A., & Heldin, C. (2001) · PubMed · Cited by 279
Barraclough, B. M. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92691-x · Cited by 279
Hampton, J. R., Henderson, R., Julian, D. G., et al. (1993) · PubMed · Cited by 273
Casali, P. G., Messina, A., Stacchiotti, S., Tamborini, E., Crippa, F., Gronchi, A., Orlandi, R., Ripamonti, C., Spreafico, C., Bertieri, R., et al. (2004) · Cancer · doi:10.1002/cncr.20618 · Cited by 268
Therapy of the Hypereosinophilic Syndrome
PARRILLO, J. E., FAUCI, A. S., & WOLFF, S. M. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-2-167 · Cited by 259
(2001) · PubMed · Cited by 257
PDGF alpha- and beta-receptors activate unique and common signal transduction pathways.
Eriksson, A., Siegbahn, A., Westermark, B., Heldin, C. H., & Claesson-Welsh, L. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05085.x · Cited by 256
Tohma, Y., Gratas, C., Biernat, W., Peraud, A., Fukuda, M., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199807000-00005 · Cited by 256
Hermanson, M., Funa, K., Koopmann, J., Maintz, D. C., Waha, A., Westermark, B., Heldin, C. H., Wiestler, O. D., Louis, D. N., von Deimling, A., et al. (1996) · PubMed · Cited by 255
Siegbahn, A., Hammacher, A., Westermark, B., & Heldin, C. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114519 · Cited by 255
Chromosomal Localization of the Human Homolog (c- sis ) of the Simian Sarcoma Virus onc Gene
Dalla-Favera, R., Gallo, R. C., Giallongo, A., & Croce, C. M. (1982) · Science · doi:10.1126/science.6291150 · Cited by 254
Regulation and role of PDGF receptor a-subunit expression during embryogenesis
Schatteman, G. C., Morrison-Graham, K., Koppen, A. V., Weston, J. A., & Bowen-Pope, D. F. (1992) · Development · doi:10.1242/dev.115.1.123 · Cited by 239
Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration
Curnis, F., Sacchi, A., & Corti, A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15223 · Cited by 238
Cao, R., Bråkenhielm, E., Li, X., Pietras, K., Widenfalk, J., Östman, A., Eriksson, U., & Cao, Y. (2002) · The FASEB Journal · doi:10.1096/fj.02-0319com · Cited by 229
Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration
Curnis, F., Sacchi, A., & Corti, A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215223 · Cited by 228
New Members of the Platelet-Derived Growth Factor Family of Mitogens
Heldin, C.-H., Eriksson, U., & Östman, A. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2707 · Cited by 221
Smits, A., Kato, M., Westermark, B., Nistér, M., Heldin, C. H., & Funa, K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.18.8159 · Cited by 220
The Janus Protein Tyrosine Kinase Family and Its Role in Cytokine Signaling
Ihle, J. N. (1995) · Advances in Immunology · doi:10.1016/s0065-2776(08)60582-9 · Cited by 212
Mechanism of epidermal growth factor receptor autophosphorylation and high-affinity binding.
Böni-Schnetzler, M., & Pilch, P. F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.22.7832 · Cited by 205
Furuhashi, M., Sjöblom, T., Abramsson, A., Ellingsen, J., Micke, P., Li, H., Bergsten-Folestad, E., Eriksson, U., Heuchel, R., Betsholtz, C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1489 · Cited by 203
Involvement of platelet-derived growth factor in disease: development of specific antagonists
(2001) · Advances in Cancer Research · doi:10.1016/s0065-230x(01)80010-5 · Cited by 202
Uutela, M., Wirzenius, M., Paavonen, K., Rajantie, I., He, Y., Karpanen, T., Lohela, M., Wiig, H., Salven, P., Pajusola, K., et al. (2004) · Blood · doi:10.1182/blood-2004-04-1485 · Cited by 198
Peptide Growth Factors and Their Receptors I
(1990) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-49295-2 · Cited by 193
Taghian, A. G., Abi-Raad, R., Assaad, S. I., Casty, A., Ancukiewicz, M., Yeh, E., Molokhia, P., Attia, K., Sullivan, T., Kuter, I., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.119 · Cited by 192
The Role of Radiation Therapy in the Management of Dermatofibrosarcoma Protuberans
Ballo M.D., M. T., Zagars M.D., G. K., Pisters M.D., P., & Pollack M.D., P. D. (1998) · International Journal of Radiation OncologyBiologyPhysics · doi:10.1016/s0360-3016(97)00895-x · Cited by 180
Roh, H., Boucher, Y., Kalnicki, S., Buchsbaum, R., Bloomer, W. D., & Jain, R. K. (1991) · PubMed · Cited by 180
Maxwell, M., Naber, S. P., Wolfe, H. J., Galanopoulos, T., Hedley-Whyte, E. T., Black, P. M., & Antoniades, H. N. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114675 · Cited by 179
Nistér, M., Claesson-Welsh, L., Eriksson, A., Heldin, C. H., & Westermark, B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55365-5 · Cited by 178
Bos, J. L. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00015-2 · Cited by 177
Brain and other central nervous system tumors: rates, trends, and epidemiology
Gurney, J. G., & Kadan-Lottick, N. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200105000-00005 · Cited by 175
What brings pericytes to tumor vessels?
Jain, R. K., & Booth, M. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320087 · Cited by 175
Hwang, R. F., Yokoi, K., Bucana, C. D., Tsan, R. Z., Killion, J. J., Evans, D. B., & Fidler, I. J. (2003) · PubMed · Cited by 158
PDGF-D is a potent transforming and angiogenic growth factor
Li, H., Fredriksson, L., Li, X., & Eriksson, U. (2003) · Oncogene · doi:10.1038/sj.onc.1206223 · Cited by 157
Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis.
Gesualdo, L., Pinzani, M., Floriano, J. J., Hassan, M. O., Nagy, N. U., Schena, F. P., Emancipator, S. N., & Abboud, H. E. (1991) · PubMed · Cited by 155
Maresta, A., Balducelli, M., Cantini, L., et al. (1994) · Circulation · doi:10.1161/01.cir.90.6.2710 · Cited by 152
Wiig, H., Rubin, K., & Reed, R. K. (2003) · Acta Anaesthesiologica Scandinavica · doi:10.1034/j.1399-6576.2003.00050.x · Cited by 149
Vascular endothelial growth factors VEGF-B and VEGF-C
Joukov, V., Kaipainen, A., Jeltsch, M., Pajusola, K., Olofsson, B., Kumar, V., Eriksson, U., & Alitalo, K. K. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199711)173:2<211::aid-jcp23>3.0.co;2-h · Cited by 148
Rice, A. B., Moomaw, C. R., Morgan, D. L., & Bonner, J. C. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65115-2 · Cited by 148
Kinnman, N., Hultcrantz, R. W., Barbu, V., Rey, C., Wendum, D., Poupon, R. Y., & Housset, C. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780073 · Cited by 145
Sundberg, C., Ljungström, M., Lindmark, G. E., Gerdin, B., & Rubin, K. (1993) · PubMed · Cited by 143
Imatinib Attenuates Diabetes-Associated Atherosclerosis
Lassila, M., Allen, T. J., Cao, Z., Thallas, V., Jandeleit-Dahm, K. A. M., Candido, R., & Cooper, M. E. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000124105.39900.db · Cited by 142
A novel physiological function for platelet‐derived growth factor‐BB in rat dermis.
Rodt, S. Å., Åhlén, K., Berg, A., Rubin, K., & Reed, R. K. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021584 · Cited by 136
Magnússon, M. K., Meade, K. E., Brown, K. E., et al. (2001) · Blood · doi:10.1182/blood.v98.8.2518 · Cited by 135
Terracio, L., Rönnstrand, L., Tingström, A., Rubin, K., Claesson, L., Funa, K., & Heldin, C. H. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.107.5.1947 · Cited by 135
Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451
Roberts, W. G., Whalen, P. M., Söderström, E., Moraski, G. C., Lyssikatos, J. P., Wang, H. F., Cooper, B. A., Baker, D. A., Savage, D. M., Dalvie, D., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.957.65.3 · Cited by 132
Expression of platelet-derived growth factor in a model of acute liver injury†
Pinzani, M., Milani, S., Grappone, C., Weber, F. L., Geñtilini, P., & Abboud, H. E. (1994) · Hepatology · doi:10.1002/hep.1840190323 · Cited by 132
Hoyle, G. W., Li, J., Finkelstein, J. B., Eisenberg, T., Liu, J., Lasky, J. A., Athas, G., Morris, G. F., & Brody, A. R. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65432-6 · Cited by 131
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors
Sandberg, A. A., & Bridge, J. A. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(02)00848-8 · Cited by 130
Alpers, C. E., Seifert, R. A., Hudkins, K. L., Johnson, R. J., & Bowen‐Pope, D. F. (1992) · Kidney International · doi:10.1038/ki.1992.300 · Cited by 128
Tyrosine kinase fusion genes in chronic myeloproliferative diseases
Cross, N. C. P., & Reiter, A. (2002) · Leukemia · doi:10.1038/sj.leu.2402556 · Cited by 126
Activated Jak2 with the V617F Point Mutation Promotes G1/S Phase Transition
Walz, C., Crowley, B. J., Hudon, H. E., Gramlich, J. L., Neuberg, D. S., Podar, K., Griffin, J. D., & Sattler, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600064200 · Cited by 117
Wilkinson, K., Velloso, E. D. R. P., Lopes, L. F., Lee, C., Aster, J. C., Shipp, M. A., & Aguiar, R. C. T. (2003) · Blood · doi:10.1182/blood-2003-04-1150 · Cited by 116
Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate
Ault, P. S., Cortes, J. E., Koller, C. A., Kaled, E. S., & Kantarjian, H. M. (2002) · Leukemia Research · doi:10.1016/s0145-2126(02)00046-2 · Cited by 116
Self-citationA human brain tumor-derived PDGFR-α deletion mutant is transforming
Clarke, I. D., & Dirks, P. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206160 · Cited by 113
Taverna, D., Groner, B., & Hynes, N. E. (1991) · PubMed · Cited by 110
Nait‐Oumesmar, B., Vignais, L., & Evercooren, A. B. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-01-00125.1997 · Cited by 110
Sun, J., Wang, D.-A., Jain, R. K., Carie, A., Paquette, S., Ennis, E., Blaskovich, M. A., Baldini, L., Coppola, D., Hamilton, A. D., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208391 · Cited by 108
Cortes, J. E., Giles, F. J., O'Brien, S. M., Thomas, D. A., Albitar, M. X., Rios, M. B., Talpaz, M., Garcia‐Manero, G., Faderl, S. H., Letvak, L. A., et al. (2003) · Cancer · doi:10.1002/cncr.11416 · Cited by 104
Self-citationGesualdo, L., Paolo, S. D., Milani, S., Pinzani, M., Grappone, C., Ranieri, E., Pannarale, G., & Schena, F. P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117348 · Cited by 104
Role of Platelet-Derived Growth Factor in Renal Injury
Abboud, H. E. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.001501 · Cited by 102
Yu, J. C., Heidaran, M. A., Pierce, J. H., Gutkind, J. S., Lombardi, D. P., Ruggiero, M., & Aaronson, S. A. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.7.3780 · Cited by 100
Bousse‐Kerdilès, M. L., & Martyré, M. C. (1999) · Annals of Hematology · doi:10.1007/s002770050595 · Cited by 99
The Use of Cell Markers in The Study of Human Hematopoietic Neoplasia
Raskind, W. H., & Fialkow, P. J. (1987) · Advances in cancer research · doi:10.1016/s0065-230x(08)60796-4 · Cited by 96
VEGFR-2-specific ligand VEGF-E induces non-edematous hyper-vascularization in mice
Kiba, A., Sagara, H., Hara, T., & Shibuya, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)03033-4 · Cited by 96
Vassbotn, F. S., Havnen, O. K., Heldin, C., et al. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36728-5 · Cited by 95
Kozaki, K., Kaminski, W. E., Tang, J., Hollenbach, S., Lindahl, P., Sullivan, C. M., Yu, J.-C., Abe, K. Y., Martin, P. J., Ross, R., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64415-x · Cited by 92
Platelet-derived growth factor is a potent biologic response modifier of T cells.
Daynes, R. A., Dowell, T., & Araneo, B. A. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.6.1323 · Cited by 92
Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differences
Broxterman, H. J., Lankelma, J., & Hoekman, K. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00026-8 · Cited by 91
Rini, B. I. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.4.453 · Cited by 91
Platelet-Derived Growth Factor
Ross, R. (1987) · Annual Review of Medicine · doi:10.1146/annurev.med.38.1.71 · Cited by 90
Hossain, M. Z., Peng, A., & Boynton, A. L. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199801)174:1<66::aid-jcp8>3.0.co;2-e · Cited by 80
Rutherford, C. L. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06042-x · Cited by 78
Schwann Cells Secrete a PDGF‐like Factor: Evidence for an Autocrine Growth Mechanism involving PDGF
Eccleston, P. A., Collarini, E. J., Jessen, K. R., Mirsky, R., & Richardson, W. D. (1990) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1990.tb00011.x · Cited by 77
Hosang, M., Rouge, M., Wipf, B., et al. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041400322 · Cited by 75
Platelet-derived growth factor causes pulmonary cell proliferation and collagen deposition in vivo.
Yi, E. S., Lee, H., Yin, S., Piguet, P. F., Sarosi, I., Kaufmann, S., Tarpley, J. E., Wang, N. S., & Ulich, T. R. (1996) · Europe PMC (PubMed Central) · Cited by 72
Ekman, S., Thuresson, E. R., Heldin, C., & Rönnstrand, L. (1999) · Oncogene · doi:10.1038/sj.onc.1202606 · Cited by 66
McMaster, P. D. (1946) · The Journal of Experimental Medicine · doi:10.1084/jem.84.5.473 · Cited by 64
Inaba, T., Shimano, H., Gotoda, T., Harada, K., Shimada, M., Ohsuga, J.-I., Watanabe, Y., Kawamura, M., Yazaki, Y., & Yamada, N. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80533-x · Cited by 63
Sundberg, C., Branting, M., Gerdin, B., & Rubin, K. (1997) · PubMed · Cited by 61
Increasing tumor uptake of anticancer drugs with imatinib
Pietras, K. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.03.036 · Cited by 61
Shure, D., Senior, R. M., Griffin, G. L., & Deuel, T. F. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81577-3 · Cited by 60
Rubin, K., Sj�quist, M., Gustafsson, Å., Isaksson, B., Salvesen, G. S., & Reed, R. K. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000601)86:5<636::aid-ijc6>3.0.co;2-r · Cited by 60
Role of platelet-derived growth factor in vivo
Ch, H. (1996) · Medical Entomology and Zoology · Cited by 58
Biology and treatment of malignant glioma.
Shapiro, W. R., & Shapiro, J. R. (1998) · PubMed · Cited by 56
Ludewig, D., Kosmehl, H., Sommer, M., Böhmer, F.-D., & Stein, G. (1999) · Cell and Tissue Research · doi:10.1007/s004419900118 · Cited by 55
Pietz, K., Odin, P., Funa, K., & Lindvall, O. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12326-0 · Cited by 54
Yamasaki, Y., Miyoshi, K., Oda, N., Watanabe, M., Miyake, H., Chan, J., Wang, X., Sun, L., Tang, C., McMahon, G., et al. (2001) · Circulation Research · doi:10.1161/01.res.88.6.630 · Cited by 54
Koyama, H., Nishizawà, Y., Hosoi, M., Fukumoto, S., Satō, K., Shioi, A., & Morii, H. (1996) · Circulation Research · doi:10.1161/01.res.79.4.757 · Cited by 53
Brekken, C., Hjelstuen, M., Bruland, Ø. S., & Davies, C. D. L. (2000) · PubMed · Cited by 53
Li, M., Ping, G., Plathow, C., Trinh, T., Lipson, K. E., Hauser, K., Krempien, R. C., Debus, J., Abdollahi, A., & Huber, P. E. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-79 · Cited by 52
Giles, F. J., Bellamy, W. T., Estrov, Z. E., O'Brien, S. M., Verstovšek, S., Ravandi, F., Beran, M., Bycott, P. W., Pithavala, Y. K., Steinfeldt, H. M., et al. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.10.024 · Cited by 52
Serruys, P. W. J. C. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2627 · Cited by 48
Ludewig, D., Kosmehl, H., Sommer, M., Böhmer, F., & Stein, G. (2000) · Cell and Tissue Research · doi:10.1007/s004410050009 · Cited by 45
Identification of PDGF Receptors on Human Megakaryocytes and Megakaryocytic Cell Lines
Yang, M., Khachigian, L. M., Hicks, C., Chesterman, C. N., & Chong, B. H. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657648 · Cited by 40
Rutherford, C. L., Martin, W., CARRIER, M. J., Änggård, E., & Ferns, G. A. (1997) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.1997.d01-237.x · Cited by 39
Yu, J., Lokker, N. A., Hollenbach, S. J., Apatira, M., Li, J., Betz, A., Sedlock, D. M., Oda, S., Nomoto, Y., Matsuno, K., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29489-1 · Cited by 39
Maximal PDGF-induced lung fibroblast chemotaxis requires PDGF receptor-alpha
Osornio-Vargas, Á. R., Lindroos, P. M., Coin, P. G., et al. (1996) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1996.271.1.l93 · Cited by 34
Fressinaud, C., Vallat, J., & Pouplard-Barthelaix, A. (1996) · Glia · doi:10.1002/(sici)1098-1136(199601)16:1<40::aid-glia5>3.0.co;2-f · Cited by 31
Role of Platelet-Derived Growth Factor in Vivo
Heldin, C., & Westermark, B. (1988) · Springer eBooks · doi:10.1007/978-1-4899-0185-9_7 · Cited by 30
Cortes, J. E., & Kantarjian, H. M. (2004) · Cancer · doi:10.1002/cncr.20211 · Cited by 24
Self-citationThe idiopathic hypereosinophilic syndrome
Bunc, M., KAR, Z. R., & Bručan, A. (2001) · European Journal of Emergency Medicine · doi:10.1097/00063110-200112000-00015 · Cited by 13
Expression of functional β-platelet-derived growth factor receptors on hematopoietic cell lines
de Parseval, N., Fichelson, S., Mayeux, P., Gisselbrecht, S., & Sola, B. (1993) · Cytokine · doi:10.1016/1043-4666(93)90018-z · Cited by 10
Brønstad, A., Reith, A., Berg, A., & Reed, R. K. (2002) · Microcirculation · doi:10.1038/sj.mn.7800134 · Cited by 10
Cited by
Mack, M. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.11.010 · Cited by 514
Recombinant Human Platelet-Derived Growth Factor: Biology and Clinical Applications
Hollinger, J. O., Hart, C. E., Hirsch, S. N., Lynch, S., & Friedlaender, G. E. (2008) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.g.01231 · Cited by 353
Tumor–platelet interaction in solid tumors
Buergy, D., Wenz, F., Groden, C., & Brockmann, M. A. (2012) · International Journal of Cancer · doi:10.1002/ijc.27441 · Cited by 352
Osteoinduction: A Review of Old Concepts with New Standards
Miron, R. J., & Zhang, Y. F. (2012) · Journal of Dental Research · doi:10.1177/0022034511435260 · Cited by 334
Phipps, M. C., Clem, W. C., Grunda, J. M., Clines, G. A., & Bellis, S. L. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.080 · Cited by 287
Metadata
- Authors
- Alvarez, R. H., Kantarjian, H. M., & Cortes, J. E.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 81
- Issue
- 9
- Pages
- 1241-1257
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W2031859764
- Cited by
- 334
- References
- 190
- FWCI
- 8.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.